It is a healthcare private limited company based in Pune, Maharashtra, India, established in 2016.
2016 | Pune, Maharashtra, India | Under Process Of Striking OffHabeeba Pharmaceuticals Private Limited, a under process of striking off private limited company, was established on 21 December 2016 in Pune, Maharashtra, India. Engaging in ayurvedic products & services within the trade sector, it holds CIN: U74999PN2016PTC167617. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Mohammad Shamshad Thakur (Director), Mohammad Aslam Mohammad Dawood Sarwar (Director), Akram (Director). Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at S. No. 657/8/2 Near Shelke Wasti Bibwewadi, Pune, Maharashtra, 411037.
U74999PN2016PTC167617
167617
21 December 2016
₹0.10 M
₹0.10 M
Roc Pune
Unlisted
Under Process Of Striking Off
Explore comprehensive insights into Habeeba Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mohammad Shamshad Thakur | Director | 21 Dec 2016 | Current |
| Mohammad Aslam Mohammad Dawood Sarwar | Director | 21 Dec 2016 | Current |
| Akram | Director | 21 Dec 2016 | Current |
| Sufyan Ahmed Mohammed Ibrahim Ghawte | Director | 21 Dec 2016 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Habeeba Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 17.68% decrease. The company also saw a substantial fall in profitability, with a 114.03% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1924.09%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Habeeba Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Habeeba Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Habeeba Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Habeeba Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Habeeba Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.
Progress on Habeeba Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Pune. was documented.
Mohammad Shamshad Thakur was appointed as a Director was appointed as a Director on 21 Dec 2016 & has been associated with this company since 9 years 5 days . was recorded as a recent event.
Progress on Mohammad Aslam Mohammad Dawood Sarwar was appointed as a Director was appointed as a Director on 21 Dec 2016 & has been associated with this company since 9 years 5 days . was documented.
Progress on Akram was appointed as a Director was appointed as a Director on 21 Dec 2016 & has been associated with this company since 9 years 5 days . was documented.
Sufyan Ahmed Mohammed Ibrahim Ghawte was appointed as a Director was appointed as a Director on 21 Dec 2016 & has been associated with this company since 9 years 5 days . was recorded as a recent event.
The CIN of Habeeba Pharmaceuticals Private Limited is U74999PN2016PTC167617.
Habeeba Pharmaceuticals Private Limited is headquartered at S. No. 657/8/2 Near Shelke Wasti Bibwewadi, Pune, Maharashtra, 411037.
Habeeba Pharmaceuticals Private Limited was incorporated on 21 December 2016.
The current directors of Habeeba Pharmaceuticals Private Limited are
The primary industry of Habeeba Pharmaceuticals Private Limited is Trade.
Habeeba Pharmaceuticals Private Limited is unlisted.
The authorized capital of Habeeba Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Habeeba Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX